Several adverse health outcomes are associated with AD, such as atopic and allergic conditions, immune mediated conditions, and more.

Monoclonal antibody benralizumab was found to be more effective than the standard treatment in a clinical trial.

The antibody drug benralizumab is on the fast track to becoming the first new treatment for certain kinds of asthma and COPD ...

Some over-the-counter medications can be used to treat symptoms of the common cold. But not all of them are effective.

The U.S. public, forever hopeful of finding a cure for the common cold, was eagerly buying newfangled pills last week. The drugs, heretofore available only on a doctor's prescription, were ...

Asthma is a serious respiratory disease in which the respiratory tract gets swollen. With the onset of winter, adults as well ...

The first new treatment for asthma attacks in 50 years is a drug already available—and it’s 4x more effective than steroid ...

Treatment for asthma and chronic obstructive pulmonary disease (COPD), which contributed to Sinead O'Connor's death last year ...

A new study reveals benralizumab, an injectable drug, shows promise in reducing asthma and COPD flare-ups, outperforming traditional steroid treatments and minimizing side effects. The drug targets ...

The study demonstrated that asthma treatment is safe, with no significant side effects compared to past studies of the drug.

Researchers at King's College London have found a new treatment for asthma attacks, which could be a 'game-changer' for the patients.

To join the webcast, please visit this link or the News & Events page of the Investors section on the Company’s website https://apogeetherapeutics.com. A replay of the webcast will be archived and ...